Mathias Vrolix

5.8k total citations · 2 hit papers
58 papers, 2.4k citations indexed

About

Mathias Vrolix is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Mathias Vrolix has authored 58 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 44 papers in Cardiology and Cardiovascular Medicine, 39 papers in Surgery and 16 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Mathias Vrolix's work include Coronary Interventions and Diagnostics (33 papers), Acute Myocardial Infarction Research (21 papers) and Cardiac Valve Diseases and Treatments (15 papers). Mathias Vrolix is often cited by papers focused on Coronary Interventions and Diagnostics (33 papers), Acute Myocardial Infarction Research (21 papers) and Cardiac Valve Diseases and Treatments (15 papers). Mathias Vrolix collaborates with scholars based in Belgium, Netherlands and Italy. Mathias Vrolix's co-authors include Tom Adriaenssens, Willem J.M. Dewilde, Jurriën M. ten Berg, Johannes C. Kelder, Freek W.A. Verheugt, Arnoud W.J. van ‘t Hof, Jean‐Paul R. Herrman, Tom Oirbans, Marije M. Vis and Victor Legrand and has published in prestigious journals such as The Lancet, Circulation and Journal of the American College of Cardiology.

In The Last Decade

Mathias Vrolix

56 papers receiving 2.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Use of clopidogrel with or without aspirin in patients taking oral anticoagulant therapy and undergoing percutaneous coronary intervention: an open-label, randomised, controlled trial

2013 1.1k citations Willem J.M. Dewilde, Freek W.A. Verheugt et al. profile →
Cardiopoietic Stem Cell Therapy in Heart Failure

2013 348 citations Jozef Bartúnek, Atta Behfar et al. Journal of the American College of Cardiology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mathias Vrolix Belgium	17	1.8k	1.2k	368	368	275	58	2.4k
Felipe Fernández‐Vázquez Spain	16	1.0k 0.6×	846 0.7×	59 0.2×	360 1.0×	163 0.6×	94	1.4k
Édouard Cheneau United States	20	1.7k 1.0×	2.0k 1.7×	176 0.5×	640 1.7×	718 2.6×	77	2.5k
Aleksander Araszkiewicz Poland	18	840 0.5×	642 0.5×	175 0.5×	240 0.7×	474 1.7×	132	1.3k
Ota Hlinomaz Czechia	16	653 0.4×	628 0.5×	57 0.2×	144 0.4×	135 0.5×	65	1.1k
Asgrimur Ragnarsson Norway	11	524 0.3×	790 0.7×	72 0.2×	152 0.4×	258 0.9×	16	1.5k
Kenneth Rosenfield United States	12	503 0.3×	509 0.4×	150 0.4×	64 0.2×	238 0.9×	40	1.3k
Alban Dibra Germany	27	2.5k 1.4×	3.2k 2.7×	82 0.2×	1.3k 3.5×	916 3.3×	55	3.6k
Romain Gallet France	19	751 0.4×	544 0.5×	54 0.1×	140 0.4×	108 0.4×	60	1.6k
Petros Okubagzi United States	21	1.2k 0.7×	545 0.5×	29 0.1×	211 0.6×	424 1.5×	49	1.6k
Jan Horstkotte Germany	13	547 0.3×	335 0.3×	685 1.9×	61 0.2×	68 0.2×	16	1.4k

Countries citing papers authored by Mathias Vrolix

Since Specialization

Citations

This map shows the geographic impact of Mathias Vrolix's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mathias Vrolix with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mathias Vrolix more than expected).

Fields of papers citing papers by Mathias Vrolix

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mathias Vrolix. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mathias Vrolix. The network helps show where Mathias Vrolix may publish in the future.

Co-authorship network of co-authors of Mathias Vrolix

This figure shows the co-authorship network connecting the top 25 collaborators of Mathias Vrolix. A scholar is included among the top collaborators of Mathias Vrolix based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mathias Vrolix. Mathias Vrolix is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Saito, Shigeru, Johan Bennett, Holger Nef, et al.. (2025). Percutaneous Coronary Treatment With Bioadaptor Implant vs Drug-Eluting Stent. JACC: Cardiovascular Interventions. 18(8). 988–997. 1 indexed citations

Saito, Shigeru, Johan Bennett, Holger Nef, et al.. (2023). First randomised controlled trial comparing the sirolimus-eluting bioadaptor with the zotarolimus-eluting drug-eluting stent in patients with de novo coronary artery lesions: 12-month clinical and imaging data from the multi-centre, international, BIODAPTOR-RCT. EClinicalMedicine. 65. 102304–102304. 11 indexed citations

Ferdinande, Bert, et al.. (2023). Comparison of Radifocus versus Silverway Guidewires for Percutaneous Radial Angiography Following Failed Use of a J-Tip Guidewire. Medical Science Monitor. 29. e939429–e939429.

Verheye, Stefan, Adrian Włodarczak, Piero Montorsi, et al.. (2020). Twelve-month outcomes of 400 patients treated with a resorbable metal scaffold: insights from the BIOSOLVE-IV registry. EuroIntervention. 15(15). e1383–e1386. 29 indexed citations

Galli, Stefano, Stefan Verheye, Adrian Włodarczak, et al.. (2019). 500.01 Safety and Performance of the Resorbable Magnesium Scaffold, Magmaris in a Real-World Setting - 12-Month Follow-Up of First 600 Subjects in Biosolve-IV Registry. JACC: Cardiovascular Interventions. 12(4). S39–S39. 2 indexed citations

Verheye, Stefan, Mathias Vrolix, Indulis Kumsārs, et al.. (2017). The SABRE Trial (Sirolimus Angioplasty Balloon for Coronary In-Stent Restenosis). JACC: Cardiovascular Interventions. 10(20). 2029–2037. 46 indexed citations

Abizaid, Alexandre, Mathias Vrolix, J. Ribamar Costa, et al.. (2017). TCT-330 Multi-Center Evaluation of a Novel 120 μm Novolimus-Eluting, Fully Bioresorbable Coronary Scaffold: First Report of 6-month Imaging and 12-Month Clinical Results. Journal of the American College of Cardiology. 70(18). B135–B136. 2 indexed citations

Geuns, Robert‐Jan van, Tuncay Yetgin, Alessio La Manna, et al.. (2016). STENTYS Self-Apposing® sirolimus-eluting stent in ST-segment elevation myocardial infarction: results from the randomised APPOSITION IV trial. EuroIntervention. 11(11). e1267–e1274. 15 indexed citations

Bertrand, Philippe B., et al.. (2016). Papillary fibro-elastoma as a rare cause of rate-dependent angina: importance of diastolic coronary perfusion. European Heart Journal - Cardiovascular Imaging. 17(6). 632–632.

10.

Legrand, Dominique, Emanuele Barbato, Patrick Chenu, et al.. (2015). The STIB score: a simple clinical test to predict clopidogrel resistance.. PubMed. 70(5). 516–21. 14 indexed citations

11.

Dewilde, Willem J.M., Paul W.A. Janssen, Johannes C. Kelder, et al.. (2015). Uninterrupted oral anticoagulation versus bridging in patients with long-term oral anticoagulation during percutaneous coronary intervention: subgroup analysis from the WOEST trial. EuroIntervention. 11(4). 381–390. 21 indexed citations

12.

Wijns, William, Mathias Vrolix, Stefan Verheye, et al.. (2015). Randomised study of a bioabsorbable polymer-coated sirolimus-eluting stent: results of the DESSOLVE II trial. EuroIntervention. 10(12). 1383–1390. 26 indexed citations

13.

Barbato, Emanuele, Sonja Šalinger-Martinović, Dragan Sagić, et al.. (2015). A first-in-man clinical evaluation of Ultimaster, a new drug-eluting coronary stent system: CENTURY study. EuroIntervention. 11(5). 541–548. 26 indexed citations

14.

Nakatani, Shimpei, Yoshinobu Onuma, Yuki Ishibashi, et al.. (2015). Incidence and potential mechanism of resolved, persistent and newly acquired malapposition three days after implantation of self-expanding or balloon-expandable stents in a STEMI population: insights from optical coherence tomography in the APPOSITION II study. EuroIntervention. 11(8). 885–894. 12 indexed citations

15.

Ormiston, John A., Mark Webster, James T. Stewart, et al.. (2013). First-in-Human Evaluation of a Bioabsorbable Polymer–Coated Sirolimus-Eluting Stent. JACC: Cardiovascular Interventions. 6(10). 1026–1034. 24 indexed citations

16.

Bartúnek, Jozef, Atta Behfar, Dariouch Dolatabadi, et al.. (2013). Cardiopoietic Stem Cell Therapy in Heart Failure. Journal of the American College of Cardiology. 61(23). 2329–2338. 348 indexed citations breakdown →

17.

Wijns, William, Mathias Vrolix, Stefan Verheye, et al.. (2012). TCT-584 Nine Month Imaging and Twelve Month Clinical Results from the DESSOLVE II Randomized Trial of the MiStent® SES with Absorbable Polymer. Journal of the American College of Cardiology. 60(17). B169–B170. 1 indexed citations

18.

Geuns, Robert‐Jan van, Corrado Tamburino, Jean Fajadet, et al.. (2012). Self-Expanding Versus Balloon-Expandable Stents in Acute Myocardial Infarction: Results From the APPOSITION II Study. JACC: Cardiovascular Interventions. 5(12). 1209–1219. 62 indexed citations

19.

Carrié, Didier, Jacques Berland, Stefan Verheye, et al.. (2012). A Multicenter Randomized Trial Comparing Amphilimus- With Paclitaxel-Eluting Stents in De Novo Native Coronary Artery Lesions. Journal of the American College of Cardiology. 59(15). 1371–1376. 79 indexed citations

20.

Adriaenssens, Tom, Jo Dens, Giovanni J. Ughi, et al.. (2011). Optical coherence tomography (OCT) in PCI for in-stent restenosis (ISR): rationale and design of the SEDUCE (Safety and Efficacy of a Drug elUting balloon in Coronary artery rEstenosis) study. EuroIntervention. 7(K). K100–K105. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact